Coombs Test: Types, Purpose and Procedure
The Coombs test is a diagnostic procedure used to detect antibodies against red blood cells. It is applied in cases of suspected hemolytic anemia or blood group incompatibility.
Things worth knowing about "Coombs Test"
The Coombs test is a diagnostic procedure used to detect antibodies against red blood cells. It is applied in cases of suspected hemolytic anemia or blood group incompatibility.
What is the Coombs Test?
The Coombs test, also known as the antiglobulin test, is a laboratory diagnostic procedure used to detect antibodies and complement proteins either on the surface of red blood cells (erythrocytes) or circulating freely in the blood serum. It was developed in 1945 by scientists Robin Coombs, Arthur Mourant, and Rob Race, and remains a cornerstone of hematology and transfusion medicine to this day.
Types of the Coombs Test
Direct Coombs Test (DAT)
The direct antiglobulin test (DAT) determines whether antibodies or complement factors have already bound to red blood cells in vivo -- that is, inside the body of the patient. The patient's erythrocytes are directly exposed to the Coombs reagent (anti-human globulin). If clumping (agglutination) occurs, the test is positive.
A positive direct Coombs test may indicate:
- Autoimmune hemolytic anemia (AIHA): The immune system produces antibodies against its own red blood cells.
- Hemolytic transfusion reaction: Incompatibility following a blood transfusion.
- Hemolytic disease of the newborn (HDN): Blood group incompatibility between mother and newborn (e.g., Rh incompatibility).
- Drug-induced hemolytic anemia: Certain medications trigger the production of antibodies against red blood cells.
Indirect Coombs Test (IAT)
The indirect antiglobulin test (IAT) detects free antibodies present in the patient's serum that are capable of binding to foreign red blood cells. The patient's serum is incubated with test erythrocytes of known blood groups, and then the Coombs reagent is added.
The indirect Coombs test is primarily used for:
- Pre-transfusion crossmatching: Verifying compatibility between donor and recipient blood.
- Antibody screening during pregnancy: Detecting irregular antibodies in pregnant individuals to prevent hemolytic disease of the newborn.
- Blood group identification: Identifying unusual blood group antigens.
How Does the Test Work?
The Coombs test is based on the use of anti-human globulin (AHG), an antibody directed against human immunoglobulins (IgG) and complement factors (C3d). When antibodies are bound to erythrocytes, the AHG links these coated cells together, producing visible agglutination (clumping) that indicates a positive result.
Clinical Significance
The Coombs test plays a critical role across several medical fields:
- Hematology: Diagnosing hemolytic anemias, in which red blood cells are prematurely destroyed.
- Transfusion medicine: Ensuring blood compatibility prior to transfusions to prevent life-threatening reactions.
- Obstetrics and neonatology: Early detection of Rh incompatibility and other blood group incompatibilities between mother and child.
- Pharmacology: Identifying drug-induced hemolytic anemias.
Procedure and Process
The test requires a blood sample drawn from the patient. Depending on the type of test, either whole blood (direct test) or serum (indirect test) is processed. The sample is analyzed in the laboratory, and results are typically available within a few hours. Aside from the routine blood draw, the procedure is painless and requires no special preparation from the patient.
Interpretation of Results
A positive result indicates the presence of antibodies or complement factors. This must always be interpreted in the clinical context and will typically prompt further diagnostic steps to determine the underlying cause. A negative result largely rules out the presence of relevant antibodies, but does not necessarily exclude all forms of disease.
References
- Coombs RRA, Mourant AE, Race RR. A new test for the detection of weak and incomplete Rh agglutinins. British Journal of Experimental Pathology. 1945;26:255-266.
- Petz LD, Garratty G. Immune Hemolytic Anemias. 2nd ed. Churchill Livingstone; 2004.
- World Health Organization (WHO). The Clinical Use of Blood in Medicine, Obstetrics, Paediatrics, Surgery and Anaesthesia, Trauma and Burns. WHO Press; 2001.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Coombs Test-en